Learn ways that clinical supply strategies for late phase vary from early phase.

Strategies sponsors can enable with a supply partner in order to minimize project risk.

Cultural considerations when planning and implementing an APAC clinical supply strategy.

Summary: FastChain® demand led supply is a continuous GMP approach to secondary packaging, label printing and application, release, and regional distribution of patient kits to clinical sites based upon actual patient and site need. The FastChain® approach will...

Summary: Integrated approach from development to clinical and benefits of working with a single integrated provider.

Summary: Utilizing an integrated solution with a single provider can help ensure a smooth transition from Phase 1 into Phase 2.

Summary: As the clinical development market evolves rapidly in China, a rising number of multi-national companies are initiating early phase clinical trials in China in parallel with other sponsor countries.

Summary: View this exclusive webcast specifically designed for pharmaceutical & biotech consultants and early stage development partners. Hear three early drug development industry experts present...

Summary: Discover what challenges can occur in Phase 3 and how to address them in advance to limit potential setbacks.

Summary: Explore strategies to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges.